| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 715.000 +1.47% on 09/12/24 | | 979.000 -25.89% on 08/19/24 | -226.000 (-23.75%) since 08/16/24 |
| 3-Month | 653.000 +11.10% on 07/09/24 | | 1,349.000 -46.22% on 06/21/24 | -542.500 (-42.78%) since 06/18/24 |
| 52-Week | 653.000 +11.10% on 07/09/24 | | 1,829.000 -60.33% on 10/02/23 | -1,027.500 (-58.61%) since 09/18/23 |
December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...
/PRNewswire/ -- Indivior PLC (LSE: INDV), a global pharmaceutical company working to help change patients' lives by developing medicines to treat substance use...
/PRNewswire/ -- Indivior PLC (LSE: INDV), a leading addiction treatment company, announced that its subsidiary, Indivior Inc. (the "Company"), has reached an...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor events: Jefferies Healthcare Conference – New York...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that its registration statement on Form 20-F required for the additional U.S. listing of its ordinary...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced its financial results for the period ending March 31, 2023. The earnings release, investor...
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced that it will participate in the following investor event: Bank of America Global Healthcare Conference...
/PRNewswire/ -- Indivior PLC (LSE: INDV) ("Indivior" or the "Company") today announced that it has completed the acquisition of Opiant Pharmaceuticals, Inc....
/PRNewswire/ -- Indivior PLC (LSE: INDV) today announced 2022 Full Year Results. The earnings release, investor presentation, and webcast are available at...
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced its financial results for the period ending September 30, 2022. The earnings release, investor...
| 3rd Resistance Point | 761.667 |
| 2nd Resistance Point | 751.833 |
| 1st Resistance Point | 738.667 |
| Last Price | 725.500 |
| 1st Support Level | 715.667 |
| 2nd Support Level | 705.833 |
| 3rd Support Level | 692.667 |
| 52-Week High | 1,829.000 |
| Fibonacci 61.8% | 1,379.768 |
| Fibonacci 50% | 1,241.000 |
| Fibonacci 38.2% | 1,102.232 |
| Last Price | 725.500 |
| 52-Week Low | 653.000 |